Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

uBriGene Biosciences is a global CDMO/CRO specializing in advanced therapy medicinal products (ATMPs), founded in 2015 and headquartered in Germantown, Maryland, with operations across North America and Asia. The company provides end-to-end support from preclinical CRO services to GMP manufacturing and analytical testing for cell and gene therapies. With 100+ GMP batches, 20+ IND approvals and a strong regulatory audit record,...
uBriGene Biosciences is a global CDMO/CRO specializing in advanced therapy medicinal products (ATMPs), founded in 2015 and headquartered in Germantown, Maryland, with operations across North America and Asia. The company provides end-to-end support from preclinical CRO services to GMP manufacturing and analytical testing for cell and gene therapies. With 100+ GMP batches, 20+ IND approvals and a strong regulatory audit record, uBriGene enables efficient translation of ATMP programs from development to commercialization.

List your booth number for exhibitions, ask us